Sandoz Group AG

Swiss Stock Exchange SDZ.SW

Sandoz Group AG EBIT Margin for the year ending December 31, 2023: 3.33%

Sandoz Group AG EBIT Margin is 3.33% for the year ending December 31, 2023, a -75.01% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Sandoz Group AG EBIT Margin for the year ending December 31, 2022 was 13.31%, a -7.57% change year over year.
  • Sandoz Group AG EBIT Margin for the year ending December 31, 2021 was 14.40%, a 73.46% change year over year.
  • Sandoz Group AG EBIT Margin for the year ending December 31, 2020 was 8.30%.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Swiss Stock Exchange: SDZ.SW

Sandoz Group AG

CEO Mr. Richard Saynor
IPO Date Oct. 3, 2023
Location Switzerland
Headquarters Suurstoffi 14
Employees 22,633
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

StockViz Staff

January 15, 2025

Any question? Send us an email